Therefore, pharmacological treatment using multiple drugs such as erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) has been introduced in clinical trials for stroke patients [1,2,3,4,5,6,7]. Here, CSF3 is linked to stroke disorder.